This IDC Health Insights report highlights the ongoing transition from the use of individual eClinical applications to the use of more comprehensive eClinical platforms solutions in the life science industry. The increased focus on operational excellence, business agility, and business outcomes combined with the rise of SaaS, PaaS, and BPO is increasingly enabling life science companies of all sizes and foci to increasingly access comprehensive eClinical platform and service capabilities on demand.
"Depending on the life science sponsor company needs, 'best of breed' or 'solid and good enough' comprehensive eClinical platforms or services are becoming increasingly available with capabilities and features evolving along with changing industry needs. From a process perspective in clinical trials, operational excellence is at hand today," says Alan S. Louie, research director, IDC Health Insights.
IDC Health Insights: Life Science Research and Development Strategy and Technology Prepublished Document Sale